Awareness of metabolic concerns in patients with bipolar disorder: A survey of European psychiatrists

European Psychiatry

Volumn 23, Issue 3, 2008, Pages 169-177

  Bauer, Michael ^a   Lecrubier, Yves ^b   Suppes, Trisha ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Mania and bipolar disorders; Psychiatry in Europe

Indexed keywords

CHOLESTEROL; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ARTICLE; BIPOLAR DISORDER; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; EUROPE; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HEALTH HAZARD; HUMAN; INSULIN SENSITIVITY; INTERVIEW; LIPID BLOOD LEVEL; MEDICAL PRACTICE; MENTAL PATIENT; METABOLIC DISORDER; METABOLIC SYNDROME X; MOTOR DYSFUNCTION; PATIENT CARE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; RASH; SEDATION; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; AWARENESS; BIPOLAR DISORDER; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG MONITORING; EUROPE; EUROPEAN UNION; HUMANS; INTERNET; METABOLIC SYNDROME X; PSYCHIATRY; QUESTIONNAIRES;

EID: 40849115037     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.10.007     Document Type: Article

References (46)

1. Alberti G. Introduction to the metabolic syndrome. Eur Heart J 7 (2005) D3-D5
2. Aronne L.J., and Segal K.R. Weight gain in the treatment of mood disorders. J Clin Psychiatry 64 Suppl. 8 (2003) 22-29
3. Balkau B., Charles M.A., Drivsholm T., Borch-Johnsen K., Wareham N., Yudkin J.S., et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28 (2002) 364-376
4. Basu R., Brar J.S., Chengappa K.N., John V., Parepally H., Gershon S., et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype. Bipolar Disord 6 (2004) 314-318
5. Bosello O., and Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 1 (2000) 47-56
6. Bowden C.L., Calabrese J.R., McElroy S.L., Gyulai L., Wassef A., Petty F., et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57 (2000) 481-489
7. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar S.A., Hompland M., et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60 (2003) 392-400
8. Cassidy F., Ahearn E., and Carroll B.J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 156 (1999) 1417-1420
9. Citrome L., Blonde L., and Damatarca C. Metabolic issues in patients with severe mental illness. South Med J 98 (2005) 714-720
10. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 28 (1979) 1039-1057
11. American Diabetes Association, The American Psychiatric Association, The American Association of Clinical Endocrinologists, The North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27 (2004) 596-601
12. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. 1999;99.2:1-66.
13. Deshmukh R., and Franco K. Managing weight gain as a side effect of antidepressant therapy. Cleve Clin J Med 70 (2003) 614, 616, 618, passim
14. Elmslie J.L., Mann J.I., Silverstone J.T., Williams S.M., and Romans S.E. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 62 (2001) 486-491
15. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7 (2005) 424-430
16. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., and Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 160 (2003) 112-117
17. Fava M. Weight gain and antidepressants. J Clin Psychiatry 61 Suppl. 11 (2000) 37-41
18. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., and Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61 (2004) 1107-1115
19. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
20. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., and Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
21. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome; 2005.
22. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
23. Kalarchian M.A., Marcus M.D., Levine M.D., Haas G.L., Greeno C.G., Weissfeld L.A., et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 66 (2005) 1058-1063
24. Keck P.E., and McElroy S.L. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 64 (2003) 1426-1435
25. Ketter T.A., and Haupt D.W. Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. Curr Med Res Opin 22 (2006) 2345-2353
26. Ketter T.A., Kalali A.H., and Weisler R.H. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65 (2004) 668-673
27. Kilbourne A.M., Cornelius J.R., Han X., Pincus H.A., Shad M., Salloum I., et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 6 (2004) 368-373
28. Kolotkin R.L., Crosby R.D., Corey-Lisle P.K., Li H., and Swanson J.M. Performance of a weight-related measure of quality of life in a psychiatric sample. Qual Life Res 15 (2006) 587-596
29. Kruger S., Shugar G., and Cooke R.G. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord 19 (1996) 45-52
30. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
31. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 288 (2002) 2709-2716
32. Malhotra S., and McElroy S.L. Associations between metabolic syndrome and psychiatric disorder. Prim Psychiatry 10 (2003) 37-44
33. Marken P.A., and Pies R.W. Emerging treatments for bipolar disorder: safety and adverse effect profiles (CE) (February). Ann Pharmacother 40 (2006) 276-285
34. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck Jr. P.E., Leverich G.S., et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 63 (2002) 207-213
35. McElroy S.L., Kotwal R., Keck Jr. P.E., and Akiskal H.S. Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?. J Affect Disord 86 (2005) 107-127
36. Morriss R., and Mohammed F.A. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol 19 (2005) 94-101
37. Ramacciotti C.E., Paoli R.A., Marcacci G., Piccinni A., Burgalassi A., Dell'Osso L., et al. Relationship between bipolar illness and binge-eating disorders. Psychiatry Res 135 (2005) 165-170
38. Sachs G., Bowden C., Calabrese J.R., Ketter T., Thompson T., White R., et al. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord 8 (2006) 175-181
39. Saely C.H., Aczel S., Marte T., Langer P., Hoefle G., and Drexel H. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 90 (2005) 5698-5703
40. Suppes T., McElroy S., and Hirschfeld R. Awareness of metabolic concerns in patients with bipolar disorder: a survey of 500 US psychiatrists. Psychopharmacol Bull 40 (2007) 22-37
41. Taylor V., and Macqueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 67 (2006) 1034-1041
42. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106 (2002) 3140-3141
43. Thompson W.K., Kupfer D.J., Fagiolini A., Scott J.A., and Frank E. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry 67 (2006) 783-788
44. Vornik L.A., and Brown E.S. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 67 Suppl. 7 (2006) 24-30
45. Wildes J.E., Marcus M.D., and Fagiolini A. Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. J Clin Psychiatry 67 (2006) 904-915
46. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649